Related Experiment Video
Updated: Aug 6, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
Integrin-regulated FAK-Src signaling in normal and cancer cells
Satyajit K Mitra1, David D Schlaepfer
1The Scripps Research Institute, Department of Immunology, IMM21 10550 N. Torrey Pines Rd, La Jolla, CA 92037, USA.
Abstract:
Integrins can alter cellular behavior through the recruitment and activation of signaling proteins such as non-receptor tyrosine kinases including focal adhesion kinase (FAK) and c-Src that form a dual kinase complex. The FAK-Src complex binds to and can phosphorylate various adaptor proteins such as p130Cas and paxillin. In normal cells, multiple integrin-regulated linkages exist to activate FAK or Src. Activated FAK-Src functions to promote cell motility, cell cycle progression and cell survival. Recent studies have found that the FAK-Src complex is activated in many tumor cells and generates signals leading to tumor growth and metastasis. As both FAK and Src catalytic activities are important in promoting VEGF-associated tumor angiogenesis and protease-associated tumor metastasis, support is growing that FAK and Src may be therapeutically relevant targets in the inhibition of tumor progression.
Insights
Integrins activate focal adhesion kinase (FAK) and c-Src, promoting normal cell functions. This FAK-Src complex is also activated in tumors, driving growth and metastasis, suggesting it as a therapeutic target.
Area of Science:
- Cell biology
- Molecular oncology
- Biochemistry
Background:
- Integrins mediate cell adhesion and signaling.
- Integrins recruit and activate signaling proteins, including focal adhesion kinase (FAK) and c-Src, forming a dual kinase complex.
- This complex phosphorylates adaptor proteins like p130Cas and paxillin, influencing cellular behavior.
Purpose of the Study:
- To investigate the role of the FAK-Src complex in normal and tumor cells.
- To explore the therapeutic potential of targeting FAK and Src in cancer progression.
Main Methods:
- The abstract does not specify methods but implies biochemical and cell signaling analysis.
- Focuses on the molecular mechanisms of integrin-mediated signaling.
Main Results:
- Activated FAK-Src promotes normal cell motility, cell cycle progression, and survival.
- The FAK-Src complex is aberrantly activated in tumor cells, contributing to tumor growth and metastasis.
- FAK and Src catalytic activities are crucial for VEGF-associated tumor angiogenesis and protease-associated tumor metastasis.
Conclusions:
- The FAK-Src complex plays a critical role in both normal cellular functions and tumor progression.
- Targeting FAK and Src offers a promising therapeutic strategy for inhibiting tumor growth and metastasis.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...

